Is there a lack of a glucose monitoring and management protocol for preventing hyperglycemia and glucocorticoid-induced diabetes mellitus in leprosy reactions?

PLoS Negl Trop Dis. 2024 Jul 25;18(7):e0012298. doi: 10.1371/journal.pntd.0012298. eCollection 2024 Jul.

Authors

Douglas Eulálio Antunes^{1

2}, Diogo Fernandes Dos Santos¹, Jaqueline Andreoli Thomazelli¹, Cassio Martins Leite¹, Isabela Maria Bernardes Goulart^{1

3}

Affiliations

¹ National Reference Center for Sanitary Dermatology and Leprosy, Clinics Hospital, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil.
² State Health Department of the Federal District, Federal District, Brasília, Brazil.
³ Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlandia, Uberlandia, Minas Gerais, Brazil.

No abstract available

MeSH terms

Blood Glucose Self-Monitoring
Blood Glucose* / analysis
Diabetes Mellitus* / drug therapy
Glucocorticoids* / adverse effects
Humans
Hyperglycemia*
Leprosy* / drug therapy
Leprosy* / prevention & control

Substances

Glucocorticoids
Blood Glucose

Grants and funding

The authors received no specific funding for this work.